Gilead Sciences Inc
NASDAQ:GILD

Watchlist Manager
Gilead Sciences Inc Logo
Gilead Sciences Inc
NASDAQ:GILD
Watchlist
Price: 121.32 USD -1.06%
Market Cap: 150.5B USD

P/E
Price to Earnings

18.5
Current
21.6
Median
24
Industry
Lower than median
Lower than industry value

The Price to Earnings (P/E) ratio shows how much investors are willing to pay for each dollar of a company’s earnings. It’s calculated by dividing the company’s market value by its net income.

P/E
18.5
=
Market Cap
150.2B USD
/
Net Income
8.1B USD
All Countries
Close
Earnings Growth PEG
US
Gilead Sciences Inc
NASDAQ:GILD
Average P/E: 45.3
18.5
191%
0.1
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 881.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
169.8
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.4
44%
0.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.5
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -527.8 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.6
8%
2.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -187.4 N/A N/A
AU
CSL Ltd
ASX:CSL
19.6
11%
1.8
NL
argenx SE
XBRU:ARGX
35.6
37%
1
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.1 N/A N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
14.6
2-Years Forward
P/E
13.7
3-Years Forward
P/E
12.8